MPXOF (MPX International) Net-Net Working Capital: $-0.20 (As of Mar. 2022)


What is MPX International Net-Net Working Capital?

MPX International MPXOF -99.00% Net-Net Working Capital is $-0.20 as of Mar. 2022.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

MPX International's Net-Net Working Capital for the quarter that ended in Mar. 2022 was $-0.20.

The industry rank for MPX International's Net-Net Working Capital or its related term are showing as below:

MPXOF's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.685
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

MPX International  (OTCPK:MPXOF) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


MPX International Net-Net Working Capital Related Terms


MPX International Net-Net Working Capital Historical Data

* Premium members only.

The historical data trend for MPX International's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MPX International Net-Net Working Capital Chart

MPX International Annual Data
Trend Sep18 Sep19 Sep20 Sep21
Net-Net Working Capital
-0.01 0.07 -0.08 -0.13

MPX International Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.10 -0.13 -0.16 -0.20

MPXOF vs ZTS, CTLT, VTRS: Net-Net Working Capital Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MPX International Price-to-Net-Net-Working-Capital vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where MPX International's Price-to-Net-Net-Working-Capital falls into.



MPX International Net-Net Working Capital Calculation

MPX International's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Sep. 2021 is calculated as

Net-Net Working Capital(A: Sep. 2021 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(4.891+0.75 * 0.816+0.5 * 2.605-21.96
-0-4.236)/143.861
=-0.13

MPX International's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2022 is calculated as

Net-Net Working Capital(Q: Mar. 2022 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.724+0.75 * 0.544+0.5 * 3.28-29.419
-0-2.333)/144.323
=-0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.

What does a Net-Net Working Capital of $-0.20 mean?
MPX International (MPXOF) has a Net-Net Working Capital of $-0.20 as of Mar. 2022. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on MPX International
Is MPX International's Net-Net Working Capital too high?
MPX International's current Net-Net Working Capital is $-0.20.
How does MPX International's Net-Net Working Capital compare to ZTS and CTLT?
MPX International's Net-Net Working Capital of $-0.20 can be compared against companies in the Drug Manufacturers industry. The industry median Net-Net Working Capital is 7.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Drug Manufacturers company?
The median Net-Net Working Capital among Drug Manufacturers companies is 7.69, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on MPX International For the Drug Manufacturers industry, the median Net-Net Working Capital is 7.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MPX International's current Net-Net Working Capital is $-0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPX International stock overvalued right now?
MPX International (MPXOF) has a current Net-Net Working Capital of $-0.20. The current Net-Net Working Capital is $-0.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For MPX International (MPXOF), the current Net-Net Working Capital is $-0.20 as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPX International Business Description

Address 5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.